Wang, Shasha
Fan, Guangyu
Li, Lin
He, Yajun
Lou, Ning
Xie, Tongji
Dai, Liyuan
Gao, Ruyun
Yang, Mengwei
Shi, Yuankai
Han, Xiaohong
Funding for this research was provided by:
National Natural Science Foundation of China (82172856, 81871739)
Article History
Received: 26 August 2022
Accepted: 19 March 2023
First Online: 3 April 2023
Declarations
:
: All authors declare no potential conflicts of interest.
: Study of clinical samples from included NSCLC patients treated with immunotherapy were approved by the medical ethics committee of Cancer Hospital, CAMS and PUMC (No.19–019/1804).